This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1999 Sep;23(1):18-20.

doi: 10.1038/12615.

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas

D Cappellen¹, C De Oliveira, D Ricol, S de Medina, J Bourdin, X Sastre-Garau, D Chopin, J P Thiery, F Radvanyi

Affiliations

Affiliation

¹ Laboratoire de Morphogenèse Cellulaire et Progression Tumorale, UMR 144, Centre National de la Recherche Scientifique, Institut Curie, Section de Recherche, 26 rue d'Ulm, 75248 Paris Cedex 05, France.

PMID: 10471491
DOI: 10.1038/12615

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas

D Cappellen et al. Nat Genet. 1999 Sep.

. 1999 Sep;23(1):18-20.

doi: 10.1038/12615.

Authors

D Cappellen¹, C De Oliveira, D Ricol, S de Medina, J Bourdin, X Sastre-Garau, D Chopin, J P Thiery, F Radvanyi

Affiliation

¹ Laboratoire de Morphogenèse Cellulaire et Progression Tumorale, UMR 144, Centre National de la Recherche Scientifique, Institut Curie, Section de Recherche, 26 rue d'Ulm, 75248 Paris Cedex 05, France.

PMID: 10471491
DOI: 10.1038/12615

No abstract available

PubMed Disclaimer

Similar articles

Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix.
Wu R, Connolly D, Ngelangel C, Bosch FX, Muñoz N, Cho KR. Wu R, et al. Oncogene. 2000 Nov 16;19(48):5543-6. doi: 10.1038/sj.onc.1203934. Oncogene. 2000. PMID: 11114733
Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
Dunois-Lardé C, Levrel O, Brams A, Thiery JP, Radvanyi F. Dunois-Lardé C, et al. Mol Carcinog. 2005 Mar;42(3):142-9. doi: 10.1002/mc.20075. Mol Carcinog. 2005. PMID: 15690367
Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
Gómez-Román JJ, Saenz P, Molina M, Cuevas González J, Escuredo K, Santa Cruz S, Junquera C, Simón L, Martínez A, Gutiérrez Baños JL, López-Brea M, Esparza C, Val-Bernal JF. Gómez-Román JJ, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):459-65. Clin Cancer Res. 2005. PMID: 15701828
The role of mutations and overexpression of the fibroblast growth factor receptor-3 in bladder cancer.
Wang QY, Zhao Y, Zhang R. Wang QY, et al. Minerva Med. 2015 Dec;106(6):333-7. Epub 2015 Nov 5. Minerva Med. 2015. PMID: 26542242 Review.
Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene.
Bellus GA, McIntosh I, Szabo J, Aylsworth A, Kaitila I, Francomano CA. Bellus GA, et al. Ann N Y Acad Sci. 1996 Jun 8;785:182-7. doi: 10.1111/j.1749-6632.1996.tb56257.x. Ann N Y Acad Sci. 1996. PMID: 8702125 Review. No abstract available.

See all similar articles

Cited by

Molecular biology of bladder cancer.
Martin-Doyle W, Kwiatkowski DJ. Martin-Doyle W, et al. Hematol Oncol Clin North Am. 2015 Apr;29(2):191-203, vii. doi: 10.1016/j.hoc.2014.10.002. Epub 2015 Jan 31. Hematol Oncol Clin North Am. 2015. PMID: 25836928 Free PMC article. Review.
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
von Mässenhausen A, Deng M, Billig H, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Göke F, Franzen A, Heasley L, Kirfel J, Brägelmann J, Perner S. von Mässenhausen A, et al. Target Oncol. 2016 Oct;11(5):631-642. doi: 10.1007/s11523-016-0431-z. Target Oncol. 2016. PMID: 27053219
FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.
Dutra RL, de Carvalho MB, Dos Santos M, Mercante AM, Gazito D, de Cicco R, Group G, Tajara EH, Louro ID, da Silva AM. Dutra RL, et al. PLoS One. 2012;7(11):e50747. doi: 10.1371/journal.pone.0050747. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226373 Free PMC article.
Precision Medicine in Urothelial Carcinoma: Current Markers to Guide Treatment and Promising Future Directions.
Miller EJ, Galsky MD. Miller EJ, et al. Curr Treat Options Oncol. 2023 Dec;24(12):1870-1888. doi: 10.1007/s11864-023-01151-7. Epub 2023 Dec 12. Curr Treat Options Oncol. 2023. PMID: 38085403 Review.
Bacterial Synthesis and Purification of Normal and Mutant Forms of Human FGFR3 Transmembrane Segment.
Goncharuk SA, Goncharuk MV, Mayzel ML, Lesovoy DM, Chupin VV, Bocharov EV, Arseniev AS, Kirpichnikov MP. Goncharuk SA, et al. Acta Naturae. 2011 Jul;3(3):77-84. Acta Naturae. 2011. PMID: 22649697 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information
Molecular Biology Databases
- GlyGen glycoinformatics resource
- The Weizmann Institute of Science GeneCards and MalaCards databases